Pri-Med Minneapolis

Minneapolis, MN | September 29-30, 2020

Minneapolis Convention Center

Disclosures

The following relevant financial relationships have been disclosed by faculty:  

Financial Disclosures

Robert H. Hopkins, Jr, MD, MACP, FAAP
No financial disclosures
Lee A. Lindquist, MD, MPH, MBA
No financial disclosures
Salvatore Mangione, MD
No financial disclosures
Charles Vega, MD, FAAFP
Genentech (Nov. 2019), Speakers Bureau; GlaxoSmithKline, Advisory Board
Shirah Vollmer, MD
No financial disclosures
Karol E. Watson, MD, PhD
Amarin Pharma Inc., Advisory Board; Amgen, Advisory Board; Boehringer Ingelheim Pharmaceuticals Inc. and Lilly USA, LLC, Speakers Bureau; Boehringer Ingelheim Pharmaceuticals Inc. and Lilly USA, LLC., Advisory Board; Esperion, Advisory Board

Other Disclosures

Pamela Kushner, MD, FAAFP (Reviewer):  Advisory Board and Speaker's Bureau for AstraZeneca, GlaxoSmithKline, and Janssen Pharmaceuticals, Inc.; Consulting Fee and Services Provided for Promotional Purposes for AstraZeneca and Janssen Pharmaceuticals.

Ty J. Gluckman, MD, FACC, FAHA (Clinical Advisory Board): Consultant for Abbvie Inc. and Teva Pharmaceuticals. 

All other non-faculty contributors involved in the planning, development, editing and review of the content have disclosed no relevant financial relationships.